Source: Annual Congress 2004 - Pulmonary fibrosis - new insights
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Tan, D. Ma, W. Han, Y. Chen, N. Zhong (Guangzhou, Beijing, China). The effects of chemokine-like factor1 on murine pulmonary fibrosis. Eur Respir J 2004; 24: Suppl. 48, 3023

Member's Comments

No comment yet.

Related content which might interest you: The role of epithelium-dependent fibroblast activation in pulmonary fibrosis Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema Source: International Congress 2017 – Experimental PH Year: 2017 Calcium-sensing receptor as a therapeutic target for pulmonary fibrosis Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 The effects of AMD3100, a CXCR4 antagonist, on the bleomycin-induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Antifibrotic effects of Lck inhibition on bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007 Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013